Ennovation Ventures Portfolio | The 9th Medical Health Investment Excellence Awards 2025 Announcement: Ennovation Ventures Wins the "Best Investment Institution for Innovative Pharmaceuticals" Award!
On July 30, 2025, HAOYUE Capital officially released the "9th Medical and Health Investment Excellence Awards," with Ennovation Ventures honored with the "Best Investment Firm in Innovative Pharmaceuticals of the Year" award
The "Medical and Health Investment Excellence List," meticulously crafted by Haoyue Capital, has entered its ninth year. Adhering to the foundational principles of "fairness, impartiality, openness, and neutrality," the list continues to provide an in-depth analysis of investment institutions' comprehensive strength in the medical and health industry. This includes their activity levels, transaction volumes, return performance, and post-investment value-added capabilities. The list also focuses on five core sectors: innovative pharmaceuticals, innovative medical devices, IVD and life sciences, health services and smart healthcare, and biotechnology. By selecting annual benchmark enterprises and investment forces, it aims to establish value benchmarks for the industry and drive ecosystem prosperity.
